Authors
Latest:
Roundtable: Building a Greater Understanding for Dravet SyndromeA duo of experts provide insight on various topics related to the advances in treatment options, diagnosis of the disorder, role of genetics, and potential future research and gene therapies.
Latest:
Newly Approved Donanemab Brings Another Treatment Option for Alzheimer Disease: Joel Salinas, MD, MBAThe behavioral neurologist at NYU Langone Health and chief medical officer at Isaac Health shared his reaction to the recent approval of donanemab for patients with Alzheimer disease. [WATCH TIME: 7 minutes]
Latest:
AI in Multiple Sclerosis: Expert Insights Into Limitations and OpportunitiesExperts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.
Latest:
Mechanism and Promise Behind Del-Zota for Duchenne Muscular Dystrophy: Michael Flanagan, PhDThe chief scientific officer at Avidity Biosciences provided clinical perspective on the function and mechanism of del-zota, an investigational antisense treatment in development for DMD amenable to exon 44 skipping. [WATCH TIME: 3 minutes]
Latest:
Personalized Treatment Approaches of Myopathies Based on Antibodies: Suur Bilicier, MDThe associate professor of neurology at the University of Texas Health Science Center at Houston talked about advances in the classification of inflammatory myopathies at the recently concluded 2023 MDA conference. [WATCH TIME: 4 minutes]
Latest:
Navigating Treatment Decision-Making in Multiple SclerosisIn a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?
Latest:
Advanced Imaging for Extended Stroke TreatmentWith many patients presenting with an unknown time of last known well, establishing a tissue window using advanced imaging techniques may allow for more effective intervention and better outcomes.
Latest:
Preventing Secondary Stroke: Practical Application of Updated GuidelinesExperts provide a summary of the management of commonly encountered risk factors for secondary ischemic stroke and transient ischemic attack based on the newly published 2021 AHA/ASA recommendations.
Latest:
A Clinical Preview of 2024 for Neuromuscular Disease: Richard Lewis, MDThe professor of neurology at Cedars-Sinai Medical Center shared his thoughts on potential therapies that expand management care options for patients with neuromuscular disease, in particularly for chronic inflammatory demyelinating polyneuropathy. [WATCH TIME: 4 minutes]
Latest:
AUPN Leadership Minute Episode 27: Making Your Residents HappyEpisode 28 of the AUPN Leadership Minute features Mud M Alvi, MD, of West Virginia University; and David Lee Gordon, MD, FAAN, FANA, FAHA, of University of Oklahoma. [WATCH TIME: 8 minutes]
Latest:
Enhancing Methodologies for Comprehensive Patient Outcome Analysis in Epilepsy: Derek Ems, MPH, CPHQThe health economics outcomes research specialist at UCB discussed the need for improved methodologies to have a more accurate analysis of patient outcomes beyond what administrative databases can provide. [WATCH TIME: 2 minutes]
Latest:
Exploring Animal Models to Inform Treatments for Alzheimer-Related Epileptic Activity: Christos Lisgaras, PhD, MScThe research scientist at NYU Langone Health talked about findings from preclinical data investigating epileptiform activity in mouse models of Alzheimer disease, which were presented at AES 2023. [WATCH TIME: 4 minutes]
Latest:
The Obstacle of Discrimination in Alzheimer Care: Carl V. Hill, PhD, MPHThe chief diversity, equity and inclusion officer at the Alzheimer’s Association discussed the findings of the association’s special edition of its annual Facts and Figures report.
Latest:
Patient Perspectives and the Importance of Advocacy and Support in Parkinson Disease: Lori DePorterAt ATMRD 2023, Lori DePorter, global ambassador for the PMD alliance, talked from the patient experience about the need for improved communication between care teams and support groups in Parkinson disease. [WATCH TIME: 3 minutes]
Latest:
Unmet Needs in the Multiple Sclerosis Community: Luc Truyen, MD, PhDThe global head of Development and External Affairs-Neuroscience at Janssen Pharmaceutical discussed areas of multiple sclerosis research that need more attention.
Latest:
Inclusive ALS Grant Expands Access to CNM-Au8 Therapy for ALS: Karen S. Ho, PhDThe vice president of translational medicine at Cene Nanomedicine talked about a recently funded grant that is focused on inclusivity and the collection of real-world data on the efficacy of CNM-Au8 in various stages of amyotrophic lateral sclerosis. [WATCH TIME: 7 minutes]
Latest:
Advice for Clinical Management of Multiple SclerosisDr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.
Latest:
Dedicated Efforts for Improving Sleep Quality in Pediatrics, Adolescents: Sarah Honaker, PhD; Maureen McQuillan, PhDThe duo from Indiana University School of Medicine discussed the ongoing research initiatives to better understand sleep disorders among pediatrics, and ways to improve approaches like cognitive behavioral therapy. [WATCH TIME: 4 minutes]
Latest:
AUPN Leadership Minute Episode 32: Succeeding in Basic Research as a DepartmentEpisode 32 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the VHA and Albany Medical College; and Louise McCullough, MD, PhD, of the McGovern Medical School of UTHealth. [WATCH TIME: 5 minutes]
Latest:
Promising Disease-Modifying Therapies in Parkinson DiseaseDespite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Latest:
Using a Portable Low Field MRI for Timely Diagnoses of Stroke: Annabel Sorby-Adams, PhDThe postdoctoral research fellow in neurology at Harvard Medical School talked about the potential of a portable low field MRI device to provide timely and cost-effective diagnoses for stroke. [WATCH TIME: 4 minutes]
Latest:
Insights into OPMD and Advancements in Genetic Research: Matthew Wicklund, MDThe professor of neurology at the University of Texas Health Science Center San Antonio provided clinical insights on the genetic basis of oculopharyngeal muscular dystrophy, as well as the primary challenges in diagnosing and treating the condition. [WATCH TIME: 5 minutes]
Latest:
Advancing Parkinson’s Disease Care While Maintaining Focus on DyskinesiaPanelists discuss how recent advancements in Parkinson’s disease treatments and a patient-centered approach to care are essential in managing dyskinesia while improving overall symptom control.
Latest:
Episode 5: Emerging Women-Related Research and Closing ThoughtsThe group of women neurologists provided commentary on the critical areas of women-focused research in neurology, from clinical trial participation to addressing workforce challenges.
Latest:
Efforts to Expand Neuropalliative Care for Neuromuscular Disorders: Ambereen Mehta, MD, MPHThe palliative care physician and assistant professor of medicine at Johns Hopkins Bayview Medical Center discussed the types of resources clinicians can pull from to expand neuropalliative care for patients with neuromuscular disorders. [WATCH TIME: 3 minutes]
Latest:
Understanding the Associations of Stroke and COVID-19: Matthew Schindler, MD, PhDThe assistant professor of neurology at the University of Pennsylvania discussed stroke risk among patients with COVID-19 and the need to seek neurological consultation. [WATCH TIME: 3 minutes]
Latest:
Advancing Research With Remote Blood Collection for Alzheimer Biomarkers: Hanna Huber, PhDThe researcher in the department of neurochemistry at the University of Gothenburg in Sweden discussed bloodspot cards as a promising method for collecting blood samples in Alzheimer disease research. [WATCH TIME: 4 minutes]
Latest:
Concluding Thoughts on Biosimilars in Multiple SclerosisAmy Perrin Ross, APN, Patricia Melville, NP-C, Aliza Ben-Zacharia, PhD, DNP, ANP-BC, and John Kramer, PA-C share their advice for facilitating uptake of biosimilars in clinical practices.
Latest:
Easing Neurosurgery With Newly Approved SmartFrame OR Stereotactic System: Joe BurnettThe chief executive officer of ClearPoint Neuro discussed how the company’s SmartFrame OR Stereotactic System can facilitate neurosurgery and the next steps in integrating it into clinical settings. [WATCH TIME: 4 minutes]
Latest:
Honoring the Impact of Recognition and Advocacy in MS Care: Aprile Royal, RN, BA, MEdThe manager of the BARLO MS education program at St. Michael's Hospital highlighted the significance of recognition, the pivotal role of nurses in multiple sclerosis care, and the lasting impact of mentorship and advocacy. [WATCH TIME: 5 minutes]
